Home » Topics » Regulatory » Patents

Patents
RSS

CSIR divulges tricyclic antineoplastics

Sep. 2, 2015

Karus discloses PI3K inhibitors

Sep. 2, 2015

Takeda discloses GPR6 modulators

Sep. 2, 2015

Bristol-Myers Squibb reports HIV integrase inhibitors

Sep. 2, 2015

Incyte discloses LSD1 inhibitors

Sep. 1, 2015

Lundbeck divulges BACE1 inhibitors

Sep. 1, 2015

Bristol-Myers Squibb patents HIV integrase inhibitors

Sep. 1, 2015

Takeda presents OX1 receptor antagonists

Sep. 1, 2015

Bayer discloses BRD4 inhibitors

Sep. 1, 2015

Bayer and DKFZ present inhibitors of mutated IDH1

Aug. 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...